PHASERX INC

As of September 30, 2017, PHASERX INC carries a market capitalization of 9.59M, placing it among publicly traded companies globally. Its enterprise value stands at 9.77M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2017, PHASERX INC has 11.69M shares outstanding.

These figures are as of September 30, 2017.

As of September 30, 2017, PHASERX INC maintains a current ratio of 2.14, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,807.64, indicating conservative leverage, while an interest coverage ratio of -13.74 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended September 30, 2017. Return on assets (ROA) is negative at -109.45, reflecting losses generated across the asset base.

As of the close on October 22, 2026, PHASERX INC's stock has declined approximately 99.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.

These figures cover the twelve months ended September 30, 2017. EBITDA reached -12.95M, while operating income came in at -13.04M.

As of September 30, 2017, PHASERX INC holds 5.26M in cash and equivalents against 5.44M in total debt, resulting in a net debt position of 184,000.00. Total book value stands at -301,000.00, with working capital of 3.10M providing operational flexibility.

PHASERX INC produced -12.82M in operating cash flow over the twelve months ended September 30, 2017. After subtracting -14,000.00 in capital expenditures, free cash flow totaled -12.83M - equivalent to -1.10 per share.

These figures cover the twelve months ended September 30, 2017. Free cash flow yield is negative at -133.90: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 5.55, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to PHASERX INC shareholders.